<img height="1" width="1" src="https://www.facebook.com/tr?id=414339248965737&amp;ev=PageView &amp;noscript=1">

Hybrid clinical trials with 20/20 Onsite

Accelerate enrollment, expand reach, and create a frictionless patient experience

With more than 80% of US clinical trials failing to meet their patient enrollment timelines and with an average of 30% of patients dropping out, mobile vision clinics are a game changer.

case_study

Applied Genetics Technology Company (AGTC) partners with 20/20 for their nationwide ophthalmic phase 1 and 2 clinical trials

press_release

Observational Study Confirms Eye Exams in Mobile Settings Have the Same Results as In-Office Exams

white_paper

Keeping Your Trials on Track: How Mobile Vision Clinics Are Making an Impact on Pre-screening, Screening and Retention

TAKE A TOUR

Look inside one of our state-of-the-art mobile vision clinics

Clinical Trials and Research

Support for ocular assessments or other study-specific eye procedures as part of a research protocol

Late Phase or Post-marketing

Support for safety or surveillance eye exams for patients outside of a clinical protocol

Meet 20/20 Onsite's Industry and Scientific Advisory Board

The Industry and Scientific Advisory Board (IASAB) meets quarterly to help identify patient needs, product opportunities, and market challenges associated with the provision of vision-related assessments for clinical trials and safety surveillance.

Adam Ramsey Headshot
Adam Ramsey, OD

Owner Socialite Vision

Beth Marsh Headshot (1)
Beth Marsh

Vice President of North America Sales and Marketing, Ophthalmology Apellis Pharmaceuticals

Jason Menzo Headshot
Jason Menzo

Chief Operating Officer Foundation Fighting Blindness

Headshot - Jeanne
Jeanne Hecht, Chair

Founder and CEO JTH Consulting, LLC

Jeffrey S. Heier Headshot
Jeffrey S. Heier, MD

Director of the Vitreoretinal Service and Director of Retina Research Ophthalmic Consultants of Boston (OCB)

Peter Kaiser Headshot
Peter K. Kaiser, MD

Chaney Family Endowed Chair in Ophthalmology Research and Professor of Ophthalmology Cleveland Clinic Lerner College of Medicine

Rajat Agrawal Headshot
Rajat Agrawal, MD, MS

CEO and President Retina Global

Medical Solution-1

Click below to read more about each board member's commitment to research or submit a question to be asked during our next quarterly meeting.

SIGN UP FOR UPDATES

Eyes on Research
A monthly newsletter dedicated to reasearch and insights on patient-first treatments